What Does Antidepressant Drug level Monitoring Reveal About Outpatient Treatment and Patient Adherence?
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61988987%3A17110%2F19%3AA2001XY4" target="_blank" >RIV/61988987:17110/19:A2001XY4 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00843989:_____/19:E0107718
Výsledek na webu
<a href="https://www.thieme-connect.com/products/ejournals/html/10.1055/s-0044-101838" target="_blank" >https://www.thieme-connect.com/products/ejournals/html/10.1055/s-0044-101838</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1055/s-0044-101838" target="_blank" >10.1055/s-0044-101838</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
What Does Antidepressant Drug level Monitoring Reveal About Outpatient Treatment and Patient Adherence?
Popis výsledku v původním jazyce
Introduction The evaluation of plasma levels of antidepressants may improve the treatment outcome. The aim was to verify adherence and adequacy of administered doses of antidepressants among patients hospitalized for inadequate outpatient therapeutic response. Methods Selective serotonin reuptake inhibitors or venlafaxine plasma levels were assessed on the first day of hospitalization and after 3 days of controlled administration. The patients were considered adherent if the plasma level on admission was within the interval of the minimum and maximum plasma level on the fourth day, expanded by 30%. The adequacy of antidepressant doses used during the outpatient treatment was assessed by comparing the plasma level on the fourth day with the therapeutic reference range. Results Out of 83 patients, 52 (62.7%) were adherent. The plasma levels of antidepressants on the fourth day were found to be within the therapeutic reference range in 35 (43.2%) patients. The same number manifested levels below the therapeutic reference range. In 11 (13.6%) patients, the levels were higher than recommended. No significant difference in rate of adherence was found among individual antidepressants. Conclusion The results show that antidepressant nonresponders are frequently under-dosed or nonadherent.
Název v anglickém jazyce
What Does Antidepressant Drug level Monitoring Reveal About Outpatient Treatment and Patient Adherence?
Popis výsledku anglicky
Introduction The evaluation of plasma levels of antidepressants may improve the treatment outcome. The aim was to verify adherence and adequacy of administered doses of antidepressants among patients hospitalized for inadequate outpatient therapeutic response. Methods Selective serotonin reuptake inhibitors or venlafaxine plasma levels were assessed on the first day of hospitalization and after 3 days of controlled administration. The patients were considered adherent if the plasma level on admission was within the interval of the minimum and maximum plasma level on the fourth day, expanded by 30%. The adequacy of antidepressant doses used during the outpatient treatment was assessed by comparing the plasma level on the fourth day with the therapeutic reference range. Results Out of 83 patients, 52 (62.7%) were adherent. The plasma levels of antidepressants on the fourth day were found to be within the therapeutic reference range in 35 (43.2%) patients. The same number manifested levels below the therapeutic reference range. In 11 (13.6%) patients, the levels were higher than recommended. No significant difference in rate of adherence was found among individual antidepressants. Conclusion The results show that antidepressant nonresponders are frequently under-dosed or nonadherent.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
30215 - Psychiatry
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2019
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Pharmacopsychiatry
ISSN
0176-3679
e-ISSN
1439-0795
Svazek periodika
52
Číslo periodika v rámci svazku
2
Stát vydavatele periodika
DE - Spolková republika Německo
Počet stran výsledku
6
Strana od-do
78-83
Kód UT WoS článku
000460173800004
EID výsledku v databázi Scopus
2-s2.0-85042231947